Total Funding
33
38
Total FundingSeed raised
Growth Score 33 in past quarter
-4 pts
Heat Score 38 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
142598
SynerGenetics Bioscience is a plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds.
- Johnson Ping Zhang: Founder & CEO
- Miguel Gallach: Chief Science Officer
About the Company
SynerGenetics Bioscience Inc. is a Canadian plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds. The Company is led by a management team with combined 35+ years of cannabis/hemp industry experience and a clear vision of capitalizing on the growing hemp and CBD markets. SG’s R&D team
successfully utilized proprietary technology to identify desirable plant traits to create hemp strains yielding 12%+ CBD content to address commercial hemp farming problems. With yields averaging less than 7% on many strains used by hemp farmers, the 5% difference is material – both financially and quality wise.